Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. Munich Vaccine Study Group.

Liese, J G; Stojanov, S; Zink, T H; Froeschle, J; Klepadlo, R; Kronwitter, A; Harzer, E; Jow, S; Belohradsky, B H

Liese, J G; Stojanov, S; Zink, T H; Froeschle, J; Klepadlo, R; Kronwitter, A; Harzer, E; Jow, S; Belohradsky, B H.

Affiliation

Liese JG; University Childrens Hospital Munich, Ludwig-Maximilians-Universität, Germany. Johannes.Liese@kk-i.med.uni-muenchen.de

Pediatr Infect Dis J ; 20(10): 981-8, 2001 Oct.

Article in En | MEDLINE | ID: mdl-11642633

Subject(s)

Diphtheria-Tetanus-acellular Pertussis Vaccines/adverse effects; Diphtheria-Tetanus-acellular Pertussis Vaccines/immunology; Age Factors; Child; Child, Preschool; Diphtheria-Tetanus-acellular Pertussis Vaccines/administration & dosage; Humans; Immunization, Secondary/adverse effects; Immunization, Secondary/statistics & numerical data; Treatment Outcome; Vaccines, Combined/adverse effects; Vaccines, Combined/immunology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Diphtheria-Tetanus-acellular Pertussis Vaccines Type of study: Evaluation_studies Limits: Child / Child, preschool / Humans Language: En Journal: Pediatr Infect Dis J Journal subject: DOENCAS TRANSMISSIVEIS / PEDIATRIA Year: 2001 Type: Article Affiliation country: Germany

Search on Google

XML

PubMed Links